Prediction of Paediatric Systemic Lupus Erythematosus Patients Using Machine Learning

• Published in: EAI Endorsed Transactions on Pervasive Health and Technology
• Main Author: Ponnusamy R.R.; Cheak L.C.; Ling E.C.W.; Chin L.S.
• Format: Article
• Language: English
• Published: European Alliance for Innovation 2024
• Online Access: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85198035384&doi=10.4108%2feetpht.10.6386&partnerID=40&md5=5cd7e907efbca57685e4290779e3eb37

Paediatric systemic lupus erythematosus (pSLE) is an autoimmune disease where the body's immune system attacks its own tissues, leading to organ damage. Advances in medical technology and the integration of artificial intelligence have significantly reduced the mortality rate of pSLE patients and improved their quality of life. Various studies have explored the link between environmental pollution and pSLE, utilizing machine learning to identify common gene expressions associated with the disease. However, the application of machine learning, particularly neural networks, to predict the status of pSLE patients over different timeframes remains underexplored. This study aims to demonstrate the effectiveness of support vector machines (SVMs) and neural networks in predicting the status of pSLE patients. Results show that without SMOTE balancing, both SVMs and neural networks achieved an accuracy of 68.09%, while neural networks achieved the highest accuracy of 77.78% after SMOTE balancing. Healthcare stakeholders can employ these machine learning techniques to provide early insights into patients' future health status based on their current condition, thereby improving patient outcomes. © 2024 Ponnusamy et al.